Kevin Su received a Bachelor of Science degree from the University of California, Irvine in 2000. During his time there, he worked as a research associate in the departments of Pathology, Medicine/Immunology, and Pharmacology where he conducted research for cell signaling projects, prostate cancer, Ataxia-telangiectasia (AT), and G-protein coupled receptors (GPCRs). Since joining MilliporeSigma in 2006, he has developed multiple GPCR stable cell lines for drug screening services and many of the FlowCellect™ Kits for the Guava® easyCyte flow cytometry platform. Kevin also developed the first industry autophagy stable cell lines including green fluorescent protein (GFP) and red fluorescent protein (RFP) versions in CHO and U2OS cells. Kevin also evaluated dyes for MilliporeSigma's live-cell dyes portfolio. He is currently focused on research and development of MilliporeSigma's three-dimensional (3D) organoid systems, specifically the 3dGROTM Human iPSC Derived Colon Organoids.